Meetings

Annual Meetings

2018 — Washington, DC

September 29—DSP and Board Meeting
September 30—CE Courses
October 1–October 3—Scientific Sessions





2017 — Berlin, Germany

September 23—DSP and Board Meeting
September 24—CE Courses
September 25–27—Scientific Sessions





2016 — Vancouver, Canada • September 18 to 21

Scientific topics Covered: Safety Pharmacology Across the Globe, Translational Cardiovascular Safety Pharmacology, Receptor Pharmacology, Advances in Technologies: In Vitro and In Silico Models, Practical Pharmacology, Personalized Medicine, Translational CNS and Respiratory Safety Pharmacology, State-of-the-Art Technologies and Methods, Translational Biomarkers: Bridging the Gap, Paediatric & Fetal Clinical Pharmacology, Regulatory Session, as well as SPS Oral Communications (from posters) and CSPT Trainee Presentations (from posters).


2015 — Prague, Czech Republic • September 28 to October 1

Featuring: Keynote by Prof. Dr. med. A.M. Das from Medizinische Hochschule Hannover in Hannover, Germany who spoke on Orphan Drugs in Inborn Errors of Metabolism – General Aspects and Clinical Vignettes, and Plenary Keynote on Wednesday, by David Sedmera, PhD from Charles University in Prague, who spoke on Drug Effects on the Developing Fetus: From Teratology Studies to Pharmacotherapy of Fetal Arrhythmias.

Scientific topics Covered: Central Nervous System—Issue Resolution, Cardiovascular—Cardiovascular Safety Assessment beyond the ECG, Translational Safety Biomarkers—From Preclinical to Clinical, Integrative Pharmacology—Case Studies in Diabetes and Pulmonary Arterial Hypertension, Central Nervous System—Sensory System Assessments in Safety Pharmacology, Cardiovascular—Translation of QT, Central Nervous System—Abuse Liability Potential: Current Advancements and Novel In Vitro Models—From Stem Cells to Human Tissues.



Regional Meetings

Please check back later this year for information on 2018 Regional Meetings

Past Regional Meetings

2017 SPS/NC3Rs Coventry University Regional Meeting

The workshop, co-organized by the NC3Rs, SPS, and Coventry University, brought together researchers from academia, SMEs, and the pharmaceutical industry to discuss how best to support and enable the use of human tissues in safety testing. The one-day workshop held in Coventry, United Kingdom on Wednesday May 3, 2017.

For more information and to register please visit the event page.

Organizers

Afthab Hussain (SPS Additional Meetings committee; Coventry University), Sam Jackson (NC3Rs), Helen Maddock (Inocardia Ltd; Coventry University), and Helen Prior (SPS secretary; NC3Rs)

Information

Location: Coventry, United Kingdom
Date: Wednesday, May 3, 2017
Registration Time: 10:00–10:30
Meeting Time: 10:30–16:30
Networking Reception: 16:30–18:00

 

2017 SPS/STP Northeast Regional Meeting

This joint regional meeting of the Safety Pharmacology Society and Society of Toxicologic Pathology held at Vertex Pharmaceuticals in the beautiful seaport district of Boston, Massachusetts. The program featured speakers from the region presenting on “Form Follows Function” related topics; designed to meet the interests of a wide range of attendees.

Organizers

Donald Hodges, Alfred Botchway, Alan Bass, Alison Easter, Andrew Sonderfan, Basel Assaf, Duncan Armstrong, Malar Pannirselvam, Martin Traebert, Michelle Brignac, Simon Authier, Tiffini Brabham, Amy Kim, Binod Jacob, and Tom Steinbach

View Agenda

Information

Location: Vertex Pharmaceuticals, Boston, Massachusetts
Date: Friday, May 12, 2017
Registration Time: 7:00 AM–8:00 AM
Meeting Time: 8:00 AM–4:30 PM


2016 SPS Northeast US Regional Meeting

Safety Pharmacology Innovations and Applications

The 2016 Safety Pharmacology Innovations and Application SPS Regional Meeting Goals are to:

  • Showcase the science of safety pharmacology across Pharma and Academic institutions and
  • To highlight scientific advances in the field brought about from collaborations with partner lines (i.e. Investigative Toxicology, Investigative Pathology, Academia and much more)

Organizers

Alf Botchway, Tiffini Brabham, Donald Hodges, Amy Kim, Andrew Sonderfan, Martin Traebert, and Malar Pannirselvam

View Agenda

Information

Location: Vertex Pharmaceuticals, Boston, Massachusetts
Date: Friday, May 13, 2016
Registration Time: 8:00 AM–8:30 AM
Meeting Time: 8:30 AM–5:00 PM


2016 SPS Southern California Regional Meeting

Cardio-Oncology: Where Safety Pharmacology Fits In

The symposium focused on safety pharmacology approaches to cardio-oncology from cellular assays to clinical support.

Organizers

Hugo Vargas, Mike Engwall, Jonathan Heyen, Sian Ratcliffe, and Paul Butler

View Agenda

Information

Location: Pfizer Campus, La Jolla, California
Date: Friday, June 5, 2015
Registration Time: 8:00 AM–9:00 AM
Meeting Time: 9:00 AM–4:00 PM


Sponsorship Opportunities

SPS Thanks the 2016 Annual Meeting Sponsors

With higher levels of sponsorship comes greater exposure. There are five levels of sponsorship available:

Sponsorship at this level requires a $15,000 contribution.
• Company Name displayed in the General Session
• Company Name listed in the Program
• Company Name listed in premeeting promotional pieces
• Company Name on the SPS website
• Verbal acknowledgment at the Plenary Lecture
• Verbal acknowledgment at the Awards Ceremony
• Acknowledgment on a meter board at the Annual Meeting
• Five Sponsor name badge ribbons

Sponsorship at this level requires a $10,000 contribution.
• Company Name displayed in the General Session
• Company Name listed in the Program
• Company Name listed in premeeting promotional pieces
• Company Name on the SPS website
• Verbal acknowledgment at the Plenary Lecture
• Verbal acknowledgment at the Awards Ceremony
• Acknowledgment on a meter board at the Annual Meeting
• Four Sponsor name badge ribbons

Sponsorship at this level requires a $6,000 contribution.
• Company Name displayed in the General Session
• Company Name listed in the Program
• Company Name listed in premeeting promotional pieces
• Company Name on the SPS website
• Verbal acknowledgment at the Plenary Lecture
• Verbal acknowledgment at the Awards Ceremony
• Acknowledgment on a meter board at the Annual Meeting
• Three Sponsor badge ribbons

Sponsorship at this level requires a $3,000 contribution.
• Company Name listed in the Program
• Company Name listed in premeeting promotional pieces
• Company Name on the SPS website
• Verbal acknowledgment at the Plenary Lecture
• Verbal acknowledgment at the Awards Ceremony
• Acknowledgment on a meter board at the Annual Meeting
• Two Sponsor badge ribbons

Sponsorship at this level is up to a $2,999 contribution.
• Company Name listed in the Program
• Company Name listed in premeeting promotional pieces
• Company Name on the SPS website
• Acknowledgment on a meter board at the Annual Meeting
• One Sponsor badge ribbon

Acknowledgement signs will group sponsors by level of contribution and will be displayed at the following functions:

  • Annual Business
  • Meeting Award Ceremony
  • Continuing Education Courses
  • Continuing Education Refreshment Breaks
  • Exhibit Hall Entrance
  • Plenary Lecture
  • Plenary Refreshment Breaks
  • Poster Sessions
  • Scientific Sessions
  • Scientific Session Refreshment Breaks

Award Opportunities

Distinguished Service Award

The Safety Pharmacology Society Distinguished Service Award (DSA) is an honor given to an individual who has substantially contributed to the field of Safety Pharmacology in one or more of the following areas: specific research achievements, champions of the field, lifelong contribution to the field, substantial specific contribution, visionary direction, regulatory decisions, science and technology of the field, education, mentorship in the field, collaboration between industry, academia, and regulatory.

Previous Distinguished Service Award Recipients

Junior Investigator Award

Eligible candidates for the Junior Investigator Award include students (undergraduate or graduate), technical staff, and junior scientists, postdoctoral fellows (< 5 years), and early career lab heads. The candidate should have less than 10 years experience in the field of safety pharmacology. Candidates may come from within academia, contract research organizations, pharmaceutical or biotechnology industry, government or engaged in preclinical research in safety pharmacology.

Exclusion criteria include previous Junior Travel Award winners, professors (undergraduate or graduate programs) and management personnel (e.g. laboratory head, principal investigator, or supervisor/mentor).

Previous Junior Investigator Award Recipients

Student Travel Award

Eligible candidates for the Student Travel Award include high school, undergraduate, or graduate students. Exclusion criteria include previous Student Travel Award winners.

Previous Student Travel Award Recipients